Total Funding
42
62
Total FundingNon-equity Assistance raised
Growth Score
-6 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
72613
A new digital health service that helps patients and their clinicians better understand and manage chronic disease.
- Brian Snyder: Co-founder and COO
- Ian Wharton: Founder and CEOPast Role: SuperUnion, Chief Experience Officer
About the Company
Aide is a health technology company with a mission to maximise the effectiveness of prescribed care. Our focus is on the unsustainable trajectory of healthcare utilisation caused by long-term conditions. This represents a challenge that costs the NHS £50bn and the US health system $1tr each year. Today, 70% of all primary and acute care spending is
on long-term conditions.
Aide uses conversational AI to help improve self-care alongside clinical decision-making for chronic disease. Specifically, Aide is designed to address the rising human and economic cost of comorbidity: individuals with two or more long term conditions which happens over 50% of the time. Today, Aide is live in NHS England supporting those with Asthma and Type 2 Diabetes.
